3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Infections
3
Febrile Neutropenia
3
Neutropenia
2
Neoplasms
2
Fever
2
Waldenstrom Macroglobulinemia
1
Urinary Tract Infections
1
Stomach Neoplasms
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pulmonary Arterial Hypertension
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumonia
1
Pain
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Interventions
LY3295668 erbumine
2
Everolimus
2
ziprasidone
1
enzalutamide
1
clevidipine
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sirolimus
1
Sevoflurane
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Propofol
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nitrous Oxide
1
Nifedipine
1
Nafcillin
1
Molindone
1
Midazolam
1
Methylprednisolone
1
Mass Screening
1
Lurasidone Hydrochloride
1
Lidocaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Epilepsy
×
Vancomycin
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled